Cyclerion Therapeutics In... (CYCN)

2.40

-0.27 (-10.11%)

At close: Mar 03, 2025, 3:59 PM

2.05

-14.58%

After-hours: Mar 03, 2025, 04:35 PM EST

Cyclerion Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-5.26M	-44.08M	-51.65M	-77.8M	-123.01M	-115.25M	-93.92M	-63.55M
Depreciation & Amortization	n/a	65K	472K	2.3M	2.7M	1.53M	1.75M	2.17M
Stock-Based Compensation	1.07M	6.25M	9.61M	14.99M	19.63M	12.43M	9.49M	n/a
Other Working Capital	-2.92M	-4M	988K	-3.49M	2.61M	2.81M	1.07M	3.82M
Other Non-Cash Items	-12.45M	5.24M	881K	-1.67M	751K	14.51M	12.59M	11.02M
Deferred Income Tax	n/a	-5.24M	2.76M	-2.72M	n/a	n/a	n/a	n/a
Change in Working Capital	-4.6M	-2.85M	1.41M	-7.59M	-2.29M	3.79M	1.47M	4.33M
Operating Cash Flow	-21.25M	-40.61M	-36.52M	-72.49M	-102.22M	-97.5M	-81.22M	-49.87M
Capital Expenditures	n/a	n/a	-7K	-1.52M	-6.89M	-3.44M	-1.4M	-1.45M
Acquisitions	n/a	n/a	1.46M	1.54M	173K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	10.4M	n/a	1.46M	1.54M	173K	n/a	n/a	n/a
Investing Cash Flow	10.4M	n/a	1.46M	18K	-6.71M	-3.44M	-1.4M	-1.45M
Debt Repayment	n/a	n/a	n/a	3.51M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	5.02M	29K	282K	331K	36.57M	100.94M	82.62M	51.32M
Financial Cash Flow	5.02M	29K	30.79M	28.09M	211.57M	100.94M	82.62M	51.32M
Net Cash Flow	-5.81M	-40.58M	-4.27M	-44.39M	102.62M	n/a	n/a	n/a
Free Cash Flow	-21.25M	-40.61M	-36.52M	-74.01M	-109.1M	-100.94M	-82.62M	-51.32M